angiotensin ii has been researched along with Diabetic Feet in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Champion, MM; Chang, M; Ding, D; Hesek, D; Lee, M; Mobashery, S; Nguyen, TT; Pérez, RL; Schroeder, VA; Suckow, MA; Wolter, WR | 1 |
1 other study(ies) available for angiotensin ii and Diabetic Feet
| Article | Year |
|---|---|
Expression of active matrix metalloproteinase-9 as a likely contributor to the clinical failure of aclerastide in treatment of diabetic foot ulcers.
Topics: Angiotensin II; Animals; Diabetic Foot; Female; Gene Expression Regulation, Enzymologic; Matrix Metalloproteinase 8; Matrix Metalloproteinase 9; Mice; Treatment Failure; Up-Regulation; Wound Healing | 2018 |